云南白药品牌怎么样 申请店铺

我要投票 云南白药在保健养生行业中的票数:1115 更新时间:2026-01-20
云南白药是哪个国家的品牌?「云南白药」是 云南白药集团股份有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人王明辉在1993-11-30期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云南白药品牌出海!将品牌入驻外推网,定制云南白药品牌推广信息,可以显著提高云南白药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

云南白药怎么样

云南白药由云南民间名医曲焕章先生于1902年创制,问世百年来,以其神奇的疗效被世人誉之为“伤科圣药”、“中华瑰宝”。

1971年,公司前身云南白药厂正式成立,白药开始了专业化生产。公司于1993年在深交所挂牌上市,成为云南省第一家A股上市公司。1996年,公司分别投资控股原云南地州的三家云南白药生产企业,即云南大理州制药厂、云南文山州制药厂和云南丽江药业有限公司,共同组成云南白药集团,对云南白药的生产经营实行“五统一”,为名牌战略的实施奠定了基础。1997年公司经国家批准获得自营进出口权。1999年,红塔成为白药集团第二大股东,实现了股权多元化;同年,云南省医药公司和天紫红药厂以优质资产配股方式进入云南白药集团,集团产业链从生产制造延伸到了药品流通和饮片加工领域。目前,省医药公司已成功改组为云南省医药有限公司,在云南首家通过国家GSP认证。天紫红药厂已改制为云南白药集团原生药材事业部,作为省内唯一的饮片加工企业,已于2003年顺利通过国家GMP认证。

经过30多年的发展,公司已从一个资产不足300万元的生产企业成长为一个总资产22亿多,总销售收入逾32亿元,经营涉及化学原料药、化学药制剂、中成药、中药材、生物制品、保健食品、化妆品及饮料的研制、生产及销售;糖、茶,建筑材料,装饰材料的批发、零售、代购代销;科技及经济技术咨询服务,医疗器械(二类、医用敷料类、一次性使用医疗卫生用品),日化用品等领域的云南省实力最强、品牌最优的大型医药企业集团。公司产品以云南白药系列和田七系列为主,共十种剂型七十余个产品,主要销往国内、港澳、东南亚等地区,并已进入日本、欧美等国家、地区的市场。“云南白药”商标于2002年2月被国家工商行政管理总局商标局评为中国驰名商标。

Yunnan Baiyao was created in 1902 by Mr. Qu Huanzhang, a famous folk doctor in Yunnan Province. It has been known as "the holy medicine of Traumatology" and "the treasure of China" for its magical curative effect for more than 100 years. In 1971, Yunnan Baiyao factory, the predecessor of the company, was officially established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange in 1993 and became the first A-share listed company in Yunnan Province. In 1996, the company invested and controlled three Yunnan Baiyao production enterprises in the former Yunnan Prefecture, namely Yunnan Dalizhou pharmaceutical factory, Yunnan Wenshanzhou pharmaceutical factory and Yunnan Lijiang Pharmaceutical Co., Ltd. to jointly form Yunnan Baiyao group, which implemented "Five Unifications" for the production and operation of Yunnan Baiyao, laying a foundation for the implementation of the famous brand strategy. In 1997, the company obtained the right of self import and export with the approval of the state. In 1999, Hongta became the second largest shareholder of Baiyao group, realizing equity diversification; in the same year, Yunnan pharmaceutical company and Tianzi Hongyao factory entered Yunnan Baiyao group by way of high-quality asset allotment, and the industrial chain of the group extended from production and manufacturing to the field of drug circulation and processing of decoction pieces. At present, the provincial pharmaceutical company has been successfully restructured into Yunnan Pharmaceutical Co., Ltd., the first one in Yunnan to pass the national GSP certification. Tianzihong pharmaceutical factory has been transformed into Yunnan Baiyao Group's original medicine business department. As the only processing enterprise in the province, it has successfully passed the national GMP certification in 2003. After more than 30 years of development, the company has grown from a production enterprise with less than 3 million yuan of assets to a total asset of more than 2.2 billion yuan, with a total sales revenue of more than 3.2 billion yuan. Its business involves the research, production and sales of chemical raw materials, chemical pharmaceutical preparations, Chinese patent medicines, biological products, health food, cosmetics and drinks; It is a large pharmaceutical enterprise group with the strongest strength and the best brand in Yunnan Province in the fields of sugar, tea, building materials, decoration materials wholesale, retail, purchasing and selling on behalf of others; scientific and technological and economic and technological consulting services, medical devices (class II, medical dressings, disposable medical and health products), daily chemical products, etc. The company's products are mainly Yunnan Baiyao series and Tianqi series, with a total of more than 70 dosage forms, which are mainly sold to domestic, Hong Kong, Macao, Southeast Asia and other regions, and have entered the markets of Japan, Europe and the United States and other countries and regions. "Yunnan Baiyao" trademark was awarded as China's well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

本文链接: https://brand.waitui.com/7cc1e882e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

现货黄金站上4700美元/盎司

36氪获悉,现货黄金站上4700美元/盎司,继续创纪录新高。

11分钟前

中科电气:宁德时代是公司锂电负极业务主要客户

36氪获悉,中科电气在互动平台表示,宁德时代是公司锂电负极业务的主要客户,双方有着良好长期的合作。

11分钟前

格力电器车用碳化硅芯片将量产,董明珠称未来供广汽半数芯片

格力电器总裁助理、珠海格力电子元器件有限公司总经理冯尹在大湾区化合物半导体生态应用大会上透露,格力电器碳化硅芯片工厂在量产家电用碳化硅芯片后,今年光伏储能用、物流车用碳化硅芯片也将量产。格力电器董事长董明珠几天前接待广汽集团董事长冯兴亚时笑言,未来广汽的汽车芯片中一半由格力产品替代。(第一财经)

11分钟前

2025年中国批准上市创新药,30款已纳入医保

36氪获悉,据国家医保局消息,2025年,国家药品监督管理局批准76款创新药上市(参照中国医药报统计口径),包括47个化学药品、23个生物制品(其中包括10个抗体药物、4个重组蛋白、3个细胞基因疗法、3个抗体偶联药物、1个基因疗法、1个多肽)和6个中成药,在数量创下新高的同时呈现出多元化创新疗法在中国加速上市的趋势,极大丰富了国内患者的临床治疗手段。

11分钟前

逼近5万亿,未来5年中国电网投资远超“十四五”

1月15日,国家电网正式宣布“十五五”期间(2026-2030年)固定资产投资总额将达4万亿元,较“十四五”时期增长40%,年均投资规模达8000亿元。随后,南方电网披露2026年投资规模为1800亿元,行业普遍预计南方电网“十五五”期间总投资将达1万亿元左右。据此测算,两大电网五年总投资将逼近5万亿元,这一数字远超“十三五”期间的2.64万亿元和“十四五”的2.85万亿元。(第一财经)

11分钟前

本页详细列出关于云南白药的品牌信息,含品牌所属公司介绍,云南白药所处行业的品牌地位及优势。
咨询